Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| Dlk-IN-1 | IC50 | 129.0 [1], 195.0 [2] | |
| Dlk-IN-1 | Ki | 1.9 [1], 3.0 [2] | |
| 5-[1-(Cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine | IC50 | 144.0 [1] | |
| 5-[1-(Cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine | Ki | 0.17 [1], 4.0 [2] | |
| 5-[5-[(1S,5R)-3-(Oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]-1-(2,2,2-trifluoroethyl)pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine | IC50 | 180.0 [1] | |
MLA | "Quest Database™ Mitogen-activated protein kinase kinase kinase 12 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 10 Dec. 2025, https://www.aatbio.com/data-sets/mitogen-activated-protein-kinase-kinase-kinase-12-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 10). Quest Database™ Mitogen-activated protein kinase kinase kinase 12 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/mitogen-activated-protein-kinase-kinase-kinase-12-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |